Kate Smith

Kate Smith is currently the Principal Scientist in the Development Services at BioReliance, which is part of the Merck Group. In this position she is responsible for providing technical support to both colleagues and clients on the design, execution and interpretation of viral clearance studies. Prior to transitioning into Development services, Kate was responsible for managing the team involved in the preparation of cell banks and viral seeds stocks.

Prior to joining BioReliance, Kate was a Principal Group Leader in the Purification Development Group at Lonza Biologics, plc. She has more than 18 years experience in the development, scale-up, transfer and validation of purification processes for monoclonal antibodies and recombinant proteins from mammalian cell cultures. Her area of expertise is the design and management of Viral and DNA reduction studies used to support product safety.

  • Next: 5-9 Dec 2022 Live online

Biotechnology for the Non-Biotechnologist

Live online
Focused

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

  • 18 CPD hours
  • Presented by Ms Kate Smith